Naoki Furuya

The Ohio State University, Internal medicine, Post-Doc

Followers

Following

Co-authors

Public Views

Education:
2006 M.D. St. Marianna University School of Medicine
2012 Ph.D. St. Marianna University School of Medicine

Clinical Training and Experience (Internal Medicine / Respiratory Medicine/Medical Oncology)
2006-2008 Intern and resident,
St. Marianna University School of Medicine Hospital, Kanagawa, Japan
2008-2015 Staff physician,
Department of Internal Medicine, Division of Respiratory Medicine,
St. Marianna University School of Medicine Hospital, Kanagawa, Japan
2015- Associate professor,
Department of Internal Medicine, Division of Respiratory Medicine,
St. Marianna University School of Medicine Hospital, Kanagawa, Japan
2021-　 Visiting Research Scholar
Medical Oncology, Comprehensive Cancer Center, Wexner Medical Center, Ohio State University, Columbus, Ohio, USA

less

Uploads

Papers by Naoki Furuya

Histologic transformation of epidermal growth factor receptor–mutated lung cancer

European Journal of Cancer, 2022

EBUS-GS法に鉗子口からの生理食塩液注入を併用し末梢空洞病変への到達が確認できた2例

The Journal of the Japan Society for Respiratory Endoscopy, 2015

Flexible bronchoscopy for lung cancer diagnosis in patients aged ≥85 years

Geriatrics & Gerontology International, 2021

Flexible bronchoscopy (FB) is a common modality for the diagnosis of lung cancer. Recently, the n... more Flexible bronchoscopy (FB) is a common modality for the diagnosis of lung cancer. Recently, the number of older patients with lung cancer is increasing, and FB is being utilized more for these patients. FB carried out in patients aged ≥85 years at St. Marianna University Hospital, Kawasaki, Japan, were reviewed. The indication of FB was decided on a case-by-case basis, taking into consideration the condition of the patient, which included mental status and accessibility of the lesion. Outcomes included complications, diagnostic yields, treatment options and survival after FB evaluation. From April 2015 to March 2019, 1604 diagnostic FBs were carried out. A total of 28 were carried out for the diagnosis of lung cancer (19 transbronchial lung biopsy, 9 transbronchial needle aspiration) in patients aged ≥85 years. Although there were three complications reported (pneumonia, fever, asthma exacerbation), they were successfully treated. A total of 19 cases were diagnosed with malignancy; five were treated with stereotactic body radiation therapy, five were prescribed targeted therapy, two underwent surgery and one was treated by cytotoxic monotherapy. Six patients were not included for active treatment. A total of 12 patients who received active treatment for lung cancer reported a 2-year survival rate of >60%. FB for lung cancer diagnosis in patients aged ≥85 years were carried out with acceptable safety and diagnostic yield. Considering the development of less invasive therapeutic measures for lung cancer, FB is safe and valuable in individuals aged ≥85 years suspected of lung cancer with therapeutic indications. Geriatr Gerontol Int 2021; ••: ••-••.

The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer

Nature, 2021

Naoki Furuya

Uploads

Papers by Naoki Furuya

Log In